AstraZeneca PLC (AZN) Acquires AlphaCore Pharma to Expand Drug Portfolio
4/3/2013 7:13:51 AM
More...
|
AlphaCore Pharma Granted Orphan Drug Designation for ACP-501 (rhLCAT) by European Medicines Agency
11/2/2012 8:16:18 AM
More...
|
AlphaCore Pharma Reports Positive Phase 1 Results for ACP-501 (rhLCAT) in Patients With Stable Atherosclerosis
10/9/2012 9:34:58 AM
More...
|
AlphaCore Pharma Initiates ACP-501 (rhLCAT) Clinical Trial in Patients With Coronary Artery Disease
3/30/2012 11:06:47 AM
More...
|
National Heart, Lung, and Blood Institute SMARTT Program Awards AlphaCore Pharma Funding to Manufacture Potential Treatment for Familial Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency
2/14/2012 7:25:24 AM
More...
|